Cargando…

The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022

BACKGROUND: Following external situation reports, individuals perceive risks, experience different emotional reactions, and further change their behaviors. Therefor people’s psychology will also be affected by adjustment of COVID-19 epidemic prevention and control policy, but it remains unknown what...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Mingyu, Qin, Tingting, Qiao, Kun, Bai, Xinyuan, Wang, Yao, Yang, Yutong, Bai, Yu, Gao, Jie, Li, Xingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503130/
https://www.ncbi.nlm.nih.gov/pubmed/37715191
http://dx.doi.org/10.1186/s12889-023-16699-0
_version_ 1785106459654094848
author Gu, Mingyu
Qin, Tingting
Qiao, Kun
Bai, Xinyuan
Wang, Yao
Yang, Yutong
Bai, Yu
Gao, Jie
Li, Xingming
author_facet Gu, Mingyu
Qin, Tingting
Qiao, Kun
Bai, Xinyuan
Wang, Yao
Yang, Yutong
Bai, Yu
Gao, Jie
Li, Xingming
author_sort Gu, Mingyu
collection PubMed
description BACKGROUND: Following external situation reports, individuals perceive risks, experience different emotional reactions, and further change their behaviors. Therefor people’s psychology will also be affected by adjustment of COVID-19 epidemic prevention and control policy, but it remains unknown what kind of coping behaviors will be produced due to psychology. This study defines coping behavior as “medical behavior and irrational consumption behavior after the adjustment of COVID-19 epidemic prevention and control policy in China”, assesses the prevalence of negative emotions in the Chinese population after policy adjustments, and explores how negative emotions affect people’s coping behaviors, conducts baseline research, provides references and suggestions for policy formulation. METHODS: A cross-sectional online survey was conducted during 21–28 December 2022, included sociodemographic characteristics, COVID-19 infection and irrational purchase behavior, psychological assessment, and opinion polling. Depression and anxiety status are assessed by PHQ-9 and GAD-7. The relationship between anxiety, depression and coping behavior was analyzed by Pearson χ(2) test, Fisher’s exact test and logistic regression. RESULTS: A total of 3995 infected participants were included in this study, of which 2363(59.1%) and 1194(29.9%) had depression and anxiety. There was a significant difference in clinical treatment and irrational purchase behavior between different level of depression and anxiety. Depression was a risk factor for self- medication (OR = 1.254), seeking professional treatment (OR = 1.215), using online services of medical institutions (OR = 1.320), large-scale purchases of medicines (OR = 1.154) and masks (OR = 1.096). Anxiety was a risk factor for seeking professional treatment (OR = 1.285) and large-scale purchases of masks (OR = 1.168). CONCLUSION: After the adjustment of COVID-19 epidemic prevention and control policy, patient risk perception can increase depression and anxiety. We found that associated with depression, COVID-19 patients are more likely to have medical behaviors such as self- medication, seeking professional treatment, using online services of medical institutions, and storage behaviors of medicines and masks; and anxiety associated with the coping behavior of patients to seek professional treatment and store masks in large quantities. We should improve people’s mental health, and on the other hand, we should give people effective psychological education during the epidemic. Therefore, we should set up psychological outpatient clinics in community health institutions, expanding mental health screening and guidance; relying on the psychological outpatient clinic, establish groups of people with depression or anxiety to carry out COVID-19 health education and peer education, to reduce adverse drug reactions, avoid panic seeking professional treatment and irrational purchase behavior, and protect public mental health. TRIAL REGISTRATION: This study has been approved by the Medical Ethics Committee of Capital Medical University (2023SY086), and informed consent was obtained from the study subjects before the investigation.
format Online
Article
Text
id pubmed-10503130
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105031302023-09-16 The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022 Gu, Mingyu Qin, Tingting Qiao, Kun Bai, Xinyuan Wang, Yao Yang, Yutong Bai, Yu Gao, Jie Li, Xingming BMC Public Health Research BACKGROUND: Following external situation reports, individuals perceive risks, experience different emotional reactions, and further change their behaviors. Therefor people’s psychology will also be affected by adjustment of COVID-19 epidemic prevention and control policy, but it remains unknown what kind of coping behaviors will be produced due to psychology. This study defines coping behavior as “medical behavior and irrational consumption behavior after the adjustment of COVID-19 epidemic prevention and control policy in China”, assesses the prevalence of negative emotions in the Chinese population after policy adjustments, and explores how negative emotions affect people’s coping behaviors, conducts baseline research, provides references and suggestions for policy formulation. METHODS: A cross-sectional online survey was conducted during 21–28 December 2022, included sociodemographic characteristics, COVID-19 infection and irrational purchase behavior, psychological assessment, and opinion polling. Depression and anxiety status are assessed by PHQ-9 and GAD-7. The relationship between anxiety, depression and coping behavior was analyzed by Pearson χ(2) test, Fisher’s exact test and logistic regression. RESULTS: A total of 3995 infected participants were included in this study, of which 2363(59.1%) and 1194(29.9%) had depression and anxiety. There was a significant difference in clinical treatment and irrational purchase behavior between different level of depression and anxiety. Depression was a risk factor for self- medication (OR = 1.254), seeking professional treatment (OR = 1.215), using online services of medical institutions (OR = 1.320), large-scale purchases of medicines (OR = 1.154) and masks (OR = 1.096). Anxiety was a risk factor for seeking professional treatment (OR = 1.285) and large-scale purchases of masks (OR = 1.168). CONCLUSION: After the adjustment of COVID-19 epidemic prevention and control policy, patient risk perception can increase depression and anxiety. We found that associated with depression, COVID-19 patients are more likely to have medical behaviors such as self- medication, seeking professional treatment, using online services of medical institutions, and storage behaviors of medicines and masks; and anxiety associated with the coping behavior of patients to seek professional treatment and store masks in large quantities. We should improve people’s mental health, and on the other hand, we should give people effective psychological education during the epidemic. Therefore, we should set up psychological outpatient clinics in community health institutions, expanding mental health screening and guidance; relying on the psychological outpatient clinic, establish groups of people with depression or anxiety to carry out COVID-19 health education and peer education, to reduce adverse drug reactions, avoid panic seeking professional treatment and irrational purchase behavior, and protect public mental health. TRIAL REGISTRATION: This study has been approved by the Medical Ethics Committee of Capital Medical University (2023SY086), and informed consent was obtained from the study subjects before the investigation. BioMed Central 2023-09-15 /pmc/articles/PMC10503130/ /pubmed/37715191 http://dx.doi.org/10.1186/s12889-023-16699-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gu, Mingyu
Qin, Tingting
Qiao, Kun
Bai, Xinyuan
Wang, Yao
Yang, Yutong
Bai, Yu
Gao, Jie
Li, Xingming
The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title_full The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title_fullStr The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title_full_unstemmed The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title_short The impact of COVID-19 prevention and control policy adjustment on anxiety, depression and coping behavior in China: a cross-sectional online survey, 21–28 December, 2022
title_sort impact of covid-19 prevention and control policy adjustment on anxiety, depression and coping behavior in china: a cross-sectional online survey, 21–28 december, 2022
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503130/
https://www.ncbi.nlm.nih.gov/pubmed/37715191
http://dx.doi.org/10.1186/s12889-023-16699-0
work_keys_str_mv AT gumingyu theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT qintingting theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT qiaokun theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT baixinyuan theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT wangyao theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT yangyutong theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT baiyu theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT gaojie theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT lixingming theimpactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT gumingyu impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT qintingting impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT qiaokun impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT baixinyuan impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT wangyao impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT yangyutong impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT baiyu impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT gaojie impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022
AT lixingming impactofcovid19preventionandcontrolpolicyadjustmentonanxietydepressionandcopingbehaviorinchinaacrosssectionalonlinesurvey2128december2022